Did you mean: KMart

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection …

DP Kontoyiannis, KA Marr, BJ Park… - Clinical infectious …, 2010 - academic.oup.com
Background. The incidence and epidemiology of invasive fungal infections (IFIs), a leading
cause of death among hematopoeitic stem cell transplant (HSCT) recipients, are derived …

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance

TC White, KA Marr, RA Bowden - Clinical microbiology reviews, 1998 - Am Soc Microbiol
In the past decade, the frequency of diagnosed fungal infections has risen sharply due to
several factors, including the increase in the number of immunosuppressed patients resulting …

Emerging fungal diseases

M Nucci, KA Marr - Clinical Infectious Diseases, 2005 - academic.oup.com
The epidemiology of invasive fungal infection is evolving. Yeasts other than Candida
albicans and molds other than Aspergillus fumigatus have emerged as significant causes of …

Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America

…, DR Andes, CJ Clancy, KA Marr… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and …

…, CC Kibbler, BJ Kullberg, KA Marr… - Clinical infectious …, 2008 - academic.oup.com
Background. Invasive fungal diseases are important causes of morbidity and mortality. Clarity
and uniformity in defining these infections are important factors in improving the quality of …

[HTML][HTML] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

…, JW Oestmann, WV Kern, KA Marr… - … England Journal of …, 2002 - Mass Medical Soc
Background Voriconazole is a broad-spectrum triazole that is active against aspergillus
species. We conducted a randomized trial to compare voriconazole with amphotericin B for …

Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America

…, R Herbrecht, DP Kontoyiannis, KA Marr… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

…, R Herbrecht, DP Kontoyiannis, KA Marr… - Clinical infectious …, 2008 - JSTOR
Aspergillus species have emerged as an important cause of life-threatening infections in
immunocompromised patients. This expanding population is composed of patients with …

Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses …

…, J Maertens, O Marchetti, KA Marr… - Clinical Infectious …, 2020 - academic.oup.com
Background Invasive fungal diseases (IFDs) remain important causes of morbidity and
mortality. The consensus definitions of the Infectious Diseases Group of the European …

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)

…, DP Kontoyiannis, GM Lyon, KA Marr… - Clinical Infectious …, 2010 - academic.oup.com
Background. Invasive fungal infections (IFIs) are a major cause of morbidity and mortality
among organ transplant recipients. Multicenter prospective surveillance data to determine …
Did you mean to search for: KMart